A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension
ConclusionsSpironolactone has the best evidence as add-on pharmacologic therapy in patients with RH, but data are limited.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Bisoprolol | Cardiology | Cardiovascular | Doxazosin | Heart | Hypertension | Spironolactone | Study